Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Natural Capsules Limited engages in the manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal-certified gelatin, fast-release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It also provides pharmaceutical dosage forms in capsule dosage form for pharma and neutraceutical products. In addition, the company offers steroidal APIs and derivative salts comprising prednisolone, betamethasone, dexamethasone and hydrocortisone. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.
Key Metrics
as of Sep 2026
Market Cap 226 Cr
P/E β
Div Yield 0.00 %
Book Value βΉ168.00
52w High βΉ296.00
52w Low βΉ136.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
48.71
58.45
37.75
45.80
45.20
44.97
43.83
41.22
39.18
40.22
39.98
37.52
37.70
Expenses
47.59
57.12
40.07
46.69
44.88
40.58
39.56
36.72
34.81
36.11
35.26
32.40
31.74
Operating Profit
1.12
1.33
-2.32
-0.89
0.32
4.39
4.27
4.50
4.37
4.11
4.72
5.12
5.96
OPM %
2.30
2.28
-6.15
-1.94
0.71
9.76
9.74
10.92
11.15
10.22
11.81
13.65
15.81
Other Income
2.35
0.76
0.45
0.16
0.36
0.30
0.11
0.11
0.18
0.92
0.50
0.35
0.17
Depreciation
4.33
4.28
4.36
4.29
4.21
2.16
2.33
2.35
2.28
2.20
2.19
2.17
2.11
Interest
4.97
2.89
2.85
2.68
2.53
1.64
1.54
1.65
1.49
1.40
1.24
1.16
1.33
Profit before tax
-5.83
-5.08
-9.08
-7.70
-6.06
0.89
0.51
0.61
0.78
1.43
1.79
2.14
2.69
Tax %
-1.54
-1.97
-21.70
-9.09
-8.09
41.57
78.43
201.64
21.79
32.17
32.96
27.10
32.34
Net Profit
-5.75
-4.98
-7.12
-6.99
-5.58
0.52
0.11
-0.61
0.60
0.97
1.21
1.56
1.82
EPS in Rs
-3.82
-3.32
-4.77
-6.76
-5.40
0.35
0.11
-0.60
0.64
1.04
1.30
1.68
1.96
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Sales
187.00 169.00 155.00 170.00 135.00 80.00 62.00 60.00 55.00
Expenses
188.00 151.00 135.00 135.00 110.00 68.00 56.00 55.00 49.00
Operating Profit
-1.00 18.00 20.00 35.00 26.00 11.00 5.00 5.00 6.00
OPM %
-0.50 10.00 13.00 21.00 19.00 14.00 9.00 8.00 10.00
Other Income
2.00 1.00 2.00 1.00 1.00 3.00 1.00 1.00 1.00
Interest
12.00 7.00 5.00 4.00 2.00 1.00 1.00 1.00 0.00
Depreciation
17.00 9.00 9.00 7.00 5.00 4.00 4.00 3.00 4.00
Profit before tax
-28.00 3.00 8.00 25.00 19.00 9.00 1.00 2.00 2.00
Tax %
-12.00 78.00 31.00 26.00 28.00 24.00 38.00 7.00 34.00
Net Profit
-25.00 1.00 6.00 18.00 14.00 7.00 1.00 2.00 1.00
EPS in Rs
-16.44 0.42 5.95 20.02 14.96 7.43 0.92 2.06 1.19
Dividend Payout %
0.00 0.00 0.00 5.00 5.00 9.00 43.00 32.00 56.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Equity Capital
10.00 10.00 9.00 9.00 7.00 6.00 6.00 6.00 6.00
Reserves
165.00 176.00 194.00 114.00 76.00 56.00 49.00 49.00 48.00
Borrowings
162.00 152.00 109.00 97.00 53.00 10.00 6.00 5.00 0.00
Other Liabilities
87.00 81.00 64.00 70.00 29.00 27.00 14.00 14.00 19.00
Total Liabilities
424.00 419.00 377.00 290.00 165.00 99.00 76.00 75.00 73.00
Fixed Assets
274.00 284.00 103.00 97.00 66.00 38.00 24.00 24.00 22.00
CWIP
4.00 0.00 144.00 88.00 20.00 7.00 2.00 2.00 1.00
Investments
3.00 3.00 3.00 0.00 0.00 0.00 6.00 5.00 5.00
Other Assets
143.00 133.00 127.00 105.00 79.00 54.00 45.00 43.00 45.00
Total Assets
424.00 419.00 377.00 290.00 165.00 99.00 76.00 75.00 73.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Cash from Operating Activity
11.00 27.00 -8.00 17.00 -1.00 13.00 7.00 2.00 5.00
Cash from Investing Activity
-11.00 -44.00 -73.00 -105.00 -46.00 -16.00 -6.00 -7.00 -1.00
Cash from Financing Activity
-1.00 16.00 82.00 87.00 48.00 3.00 -1.00 4.00 -4.00
Net Cash Flow
0.00 -2.00 1.00 0.00 1.00 0.00 0.00 -1.00 0.00
Free Cash Flow
-1.00 -18.00 -79.00 -88.00 -47.00 -11.00 2.00 -5.00 4.00
CFO/OP %
-1,634.00 162.00 -32.00 64.00 17.00 134.00 144.00 57.00 97.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Debtor Days
139.00 134.00 128.00 112.00 71.00 123.00 180.00 197.00 208.00
Inventory Days
94.00 109.00 88.00 45.00 34.00 82.00 89.00 87.00 149.00
Days Payable
197.00 166.00 141.00 127.00 98.00 159.00 91.00 114.00 185.00
Cash Conversion Cycle
36.00 78.00 75.00 30.00 7.00 45.00 179.00 170.00 172.00
Working Capital Days
-1.00 53.00 80.00 61.00 73.00 35.00 121.00 143.00 186.00
ROCE %
-5.00 3.00 5.00 15.00 21.00 11.00 4.00 5.00 β
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
50.92
51.04
51.26
51.26
51.26
51.21
51.13
51.59
56.57
56.57
56.57
56.57
DIIs
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.18
1.31
1.31
1.31
Public
49.09
48.96
48.74
48.73
48.75
48.80
48.86
48.39
43.25
42.13
42.13
42.13
No. of Shareholders
8,756
8,850
9,075
9,573
9,311
9,425
9,661
9,862
10,514
10,954
11,399
11,675
Corporate Actions
18 records
Back to all stocks